NCT03724370

Brief Summary

Overview. The investigators will randomize 120 Veterans in this 3-site trial over 16 months. Eligible Veterans will include those to be discharged for a hospitalization for suicidal ideation. Baseline data collection and randomization will occur at discharge. The 3 month intervention will have study assessments at 2, 4, 8, and 12 weeks post-discharge. The study's primary outcome measure is suicidal ideation (measured with the Beck Scale for Suicidal Ideation\[BSS\] and secondarily with the Columbia Scale for Suicidality C-SSRS). Intervention Components. The control condition will consist of Veterans randomized to VHA-SRM (Suicide Risk Monitoring). The experimental condition will be the telehealth system (TES) + VHA-SRM (Suicide Risk Monitoring) intervention. Veterans randomized to the telehealth system will receive the Interactive Voice Response (IVR) system monitoring in addition to VHA-SRM and will receive training on how to use the TES from the research coordinator. Veterans can access the IVR as a telephonic device accessed by a local or toll-free number and can use a 'plain old telephone system' (POTS), Cellular phone or Internet phone connected to their phone service provider. Participants will be instructed to interact daily with the TES system daily. Because of safety concerns, questions pertaining to suicidal behavior will be asked daily; to avoid repetition, all other questions will be asked every 3rd day. Once participants complete the questions on the telehealth device, their responses will be automatically uploaded and checked by trained VA Pittsburgh Healthcare System (VAPHS) nurses every 4 hours, during regular daytime hours of 9-5. VAPHS will serve as the central site retrieving downloads for all sites. Color-coded risk triage level designations based on potential responses, provide guidance regarding next steps. The protocol for assessing suicidal patients will follow standard VA procedures, outlined in each medical center's safety plan for suicidal patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
180

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 28, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 30, 2018

Completed
2 months until next milestone

Study Start

First participant enrolled

December 14, 2018

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

May 6, 2022

Status Verified

May 1, 2022

Enrollment Period

5 years

First QC Date

August 28, 2018

Last Update Submit

May 5, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Beck Scale for Suicidal Ideation (BSS). Aaron T. Beck, copyright 1991.

    Continuous scale assessing suicidal ideation. Scores will range from 0 to 42, with lower scores indicating less suicidal ideation.

    At every visit: screen, baseline(s), week 2,4,6,8,12; timeframe is the past week, including today.

Secondary Outcomes (1)

  • Change in Columbia Suicide Severity Rating Scale (C-SSRS). Posner, K; Brent, D; Lucas, c; Gould, M; Stanley, B; Brown, G; Fisher, P; Zelazny, J; Burke, A; Oquendo, M; Mann, J.

    At every visit: screen, baseline(s), week 2,4,6,8,12; time frame includes lifetime and since last visit.

Study Arms (2)

TES+ VHA-SRM

EXPERIMENTAL

Telehealth monitoring system (TES) will be added to the VA suicide risk management system (VHA-SRM)

Behavioral: Telehealth Monitoring SystemOther: VHA-SRM

VHA-SRM

ACTIVE COMPARATOR

VHA-SRM will be active comparator

Other: VHA-SRM

Interventions

TES will be conducted daily via Interactive Voice Response System (IVRS) during the 12 week study period.TES will be added to VHA-SRM.

TES+ VHA-SRM
VHA-SRMOTHER

Veterans Health Administration Suicide Risk Management supportive services will be provided to participant during the 12 weeks of study participation.

TES+ VHA-SRMVHA-SRM

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Veterans \> 18 years old;
  • any diagnosis as long as participants exhibit at least mild depressive symptoms, i.e., a Hamilton 17-item depression 30 score \>8; this includes patients with schizophrenia/schizoaffective disorder;
  • score \>1 on items 4 or 5 on the SSI ; which assesses active or passive suicidal ideation, respectively.-

You may not qualify if:

  • Cognitive problems that would interfere with Veterans' ability to manage the TES system (e.g., neurocognitive d/o, significant traumatic brain injury, or a Folstein Mini Mental Status Exam score \<22) or serious motor dexterity problems;
  • Veterans without phone access.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

VA NY Harbor Healthcare System, Manhattan Campus

New York, New York, 10010, United States

RECRUITING

James J. Peters Medical Center

The Bronx, New York, 10468, United States

RECRUITING

Related Publications (37)

  • Kemp, J & Bossarte R. (2013). Suicide data report: 2012. Department of Veterans Affairs, Mental Health Services, Suicide Prevention Program.

    BACKGROUND
  • Bruce ML. Suicide risk and prevention in veteran populations. Ann N Y Acad Sci. 2010 Oct;1208:98-103. doi: 10.1111/j.1749-6632.2010.05697.x.

    PMID: 20955331BACKGROUND
  • Zivin K, Kim HM, McCarthy JF, Austin KL, Hoggatt KJ, Walters H, Valenstein M. Suicide mortality among individuals receiving treatment for depression in the Veterans Affairs health system: associations with patient and treatment setting characteristics. Am J Public Health. 2007 Dec;97(12):2193-8. doi: 10.2105/AJPH.2007.115477. Epub 2007 Oct 30.

    PMID: 17971541BACKGROUND
  • Report of the Blue Ribbon Work Group on Suicide Prevention in the Veteran Population. Washington, DC: U.S. Department of Veterans Affairs.

    BACKGROUND
  • Department of Veterans Affairs, Inpatient Mental Health Services, VHA Handbook 1160.06, 9/16/2013

    BACKGROUND
  • Desai RA, Dausey DJ, Rosenheck RA. Mental health service delivery and suicide risk: the role of individual patient and facility factors. Am J Psychiatry. 2005 Feb;162(2):311-8. doi: 10.1176/appi.ajp.162.2.311.

    PMID: 15677596BACKGROUND
  • Valenstein M, Eisenberg D, McCarthy JF, Austin KL, Ganoczy D, Kim HM, Zivin K, Piette JD, Olfson M, Blow FC. Service implications of providing intensive monitoring during high-risk periods for suicide among VA patients with depression. Psychiatr Serv. 2009 Apr;60(4):439-44. doi: 10.1176/ps.2009.60.4.439.

    PMID: 19339317BACKGROUND
  • Hoffmire CA, Kemp JE, Bossarte RM. Changes in Suicide Mortality for Veterans and Nonveterans by Gender and History of VHA Service Use, 2000-2010. Psychiatr Serv. 2015 Sep;66(9):959-65. doi: 10.1176/appi.ps.201400031. Epub 2015 May 1.

    PMID: 25930036BACKGROUND
  • The Assessment and Management of Risk for Suicide Working Group. 2013. VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide. Retrieved from: http://www.healthquality.va.

    BACKGROUND
  • Blow FC, Bohnert AS, Ilgen MA, Ignacio R, McCarthy JF, Valenstein MM, Knox KL. Suicide mortality among patients treated by the Veterans Health Administration from 2000 to 2007. Am J Public Health. 2012 Mar;102 Suppl 1(Suppl 1):S98-104. doi: 10.2105/AJPH.2011.300441.

    PMID: 22390612BACKGROUND
  • McCarthy JF, Valenstein M, Kim HM, Ilgen M, Zivin K, Blow FC. Suicide mortality among patients receiving care in the veterans health administration health system. Am J Epidemiol. 2009 Apr 15;169(8):1033-8. doi: 10.1093/aje/kwp010. Epub 2009 Feb 27.

    PMID: 19251753BACKGROUND
  • Gibbons RD, Brown CH, Hur K, Davis J, Mann JJ. Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine. Arch Gen Psychiatry. 2012 Jun;69(6):580-7. doi: 10.1001/archgenpsychiatry.2011.2048.

    PMID: 22309973BACKGROUND
  • Almeida OP, Pirkis J, Kerse N, Sim M, Flicker L, Snowdon J, Draper B, Byrne G, Goldney R, Lautenschlager NT, Stocks N, Alfonso H, Pfaff JJ. A randomized trial to reduce the prevalence of depression and self-harm behavior in older primary care patients. Ann Fam Med. 2012 Jul-Aug;10(4):347-56. doi: 10.1370/afm.1368.

    PMID: 22778123BACKGROUND
  • Tarrier N, Taylor K, Gooding P. Cognitive-behavioral interventions to reduce suicide behavior: a systematic review and meta-analysis. Behav Modif. 2008 Jan;32(1):77-108. doi: 10.1177/0145445507304728.

    PMID: 18096973BACKGROUND
  • Valenstein M, Kim HM, Ganoczy D, Eisenberg D, Pfeiffer PN, Downing K, Hoggatt K, Ilgen M, Austin KL, Zivin K, Blow FC, McCarthy JF. Antidepressant agents and suicide death among US Department of Veterans Affairs patients in depression treatment. J Clin Psychopharmacol. 2012 Jun;32(3):346-53. doi: 10.1097/JCP.0b013e3182539f11.

    PMID: 22544011BACKGROUND
  • Bostwick JM, Pankratz VS. Affective disorders and suicide risk: a reexamination. Am J Psychiatry. 2000 Dec;157(12):1925-32. doi: 10.1176/appi.ajp.157.12.1925.

    PMID: 11097952BACKGROUND
  • Godleski L, Nieves JE, Darkins A, Lehmann L. VA telemental health: suicide assessment. Behav Sci Law. 2008;26(3):271-86. doi: 10.1002/bsl.811.

    PMID: 18548515BACKGROUND
  • Valenstein M, Kim HM, Ganoczy D, McCarthy JF, Zivin K, Austin KL, Hoggatt K, Eisenberg D, Piette JD, Blow FC, Olfson M. Higher-risk periods for suicide among VA patients receiving depression treatment: prioritizing suicide prevention efforts. J Affect Disord. 2009 Jan;112(1-3):50-8. doi: 10.1016/j.jad.2008.08.020. Epub 2008 Oct 22.

    PMID: 18945495BACKGROUND
  • While D, Bickley H, Roscoe A, Windfuhr K, Rahman S, Shaw J, Appleby L, Kapur N. Implementation of mental health service recommendations in England and Wales and suicide rates, 1997-2006: a cross-sectional and before-and-after observational study. Lancet. 2012 Mar 17;379(9820):1005-12. doi: 10.1016/S0140-6736(11)61712-1. Epub 2012 Feb 2.

    PMID: 22305767BACKGROUND
  • Mishara BL, Chagnon F, Daigle M, Balan B, Raymond S, Marcoux I, Bardon C, Campbell JK, Berman A. Which helper behaviors and intervention styles are related to better short-term outcomes in telephone crisis intervention? Results from a Silent Monitoring Study of Calls to the U.S. 1-800-SUICIDE Network. Suicide Life Threat Behav. 2007 Jun;37(3):308-21. doi: 10.1521/suli.2007.37.3.308.

    PMID: 17579543BACKGROUND
  • Kasckow J, Zickmund S, Rotondi A, Mrkva A, Gurklis J, Chinman M, Fox L, Loganathan M, Hanusa B, Haas G. Development of telehealth dialogues for monitoring suicidal patients with schizophrenia: consumer feedback. Community Ment Health J. 2014 Apr;50(3):339-42. doi: 10.1007/s10597-012-9589-8. Epub 2013 Jan 10.

    PMID: 23306676BACKGROUND
  • De Vito Dabbs A, Myers BA, Mc Curry KR, Dunbar-Jacob J, Hawkins RP, Begey A, Dew MA. User-centered design and interactive health technologies for patients. Comput Inform Nurs. 2009 May-Jun;27(3):175-83. doi: 10.1097/NCN.0b013e31819f7c7c.

    PMID: 19411947BACKGROUND
  • Rubin J. (1994). Handbook of Usability Testing: How to Plan, Design, and Conduct Effective Tests. New York, NY: John Wiley & Sons, Inc.

    BACKGROUND
  • Gould JD, Lewis C. (1985). Designing for usability: key principles and what designers think. Commun ACM. 2:300-311.

    BACKGROUND
  • Kasckow J, Zickmund S, Rotondi A, Welch A, Gurklis J, Chinman M, Fox L, Haas GL. Optimizing Scripted Dialogues for an e-Health Intervention for Suicidal Veterans with Major Depression. Community Ment Health J. 2015 Jul;51(5):509-12. doi: 10.1007/s10597-014-9775-y. Epub 2014 Oct 24.

    PMID: 25342076BACKGROUND
  • Kasckow J, Gao S, Hanusa B, Rotondi A, Chinman M, Zickmund S, Gurklis J, Fox L, Cornelius J, Richmond I, Haas GL. Telehealth Monitoring of Patients with Schizophrenia and Suicidal Ideation. Suicide Life Threat Behav. 2015 Oct;45(5):600-611. doi: 10.1111/sltb.12154. Epub 2015 Feb 17.

    PMID: 25688921BACKGROUND
  • Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: the Scale for Suicide Ideation. J Consult Clin Psychol. 1979 Apr;47(2):343-52. doi: 10.1037//0022-006x.47.2.343. No abstract available.

    PMID: 469082BACKGROUND
  • Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, Currier GW, Melvin GA, Greenhill L, Shen S, Mann JJ. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011 Dec;168(12):1266-77. doi: 10.1176/appi.ajp.2011.10111704.

    PMID: 22193671BACKGROUND
  • HAMILTON M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960 Feb;23(1):56-62. doi: 10.1136/jnnp.23.1.56. No abstract available.

    PMID: 14399272BACKGROUND
  • Beck AT, Weissman A, Lester D, Trexler L. The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol. 1974 Dec;42(6):861-5. doi: 10.1037/h0037562. No abstract available.

    PMID: 4436473BACKGROUND
  • MacArthur Sociodemographic Questionnaire. (2008). The Regents of the University of California

    BACKGROUND
  • Screening for Drug Use in General Medicine: Resource Guide. National Institute on Drug Abuse.

    BACKGROUND
  • Andreason N. Scale for Assessment of Positive Symptoms (SAPS). (1984). University of Iowa, Department of Psychiatry, Iowa City, Iowa.

    BACKGROUND
  • Svarstad BL, Chewning BA, Sleath BL, Claesson C. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999 Jun;37(2):113-24. doi: 10.1016/s0738-3991(98)00107-4.

    PMID: 14528539BACKGROUND
  • Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991;32(6):705-14. doi: 10.1016/0277-9536(91)90150-b.

    PMID: 2035047BACKGROUND
  • Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189-98. doi: 10.1016/0022-3956(75)90026-6. No abstract available.

    PMID: 1202204BACKGROUND
  • American Psychiatric Association. Structured Clinical Interview for DSM-5 (SCID-5). Arlington, 2015.

    BACKGROUND

MeSH Terms

Conditions

Suicide

Condition Hierarchy (Ancestors)

Self-Injurious BehaviorBehavioral SymptomsBehavior

Study Officials

  • Gretchen L Haas, Ph.D.

    VA Pittsburgh Healthcare System

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gretchen Haas, Ph.D.

CONTACT

Mary McShea, M.A.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PI

Study Record Dates

First Submitted

August 28, 2018

First Posted

October 30, 2018

Study Start

December 14, 2018

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

May 6, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations